Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.
Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR. Mariño-Enríquez A, et al. Among authors: ou wb. Genes Chromosomes Cancer. 2011 Mar;50(3):146-53. doi: 10.1002/gcc.20839. Epub 2010 Dec 13. Genes Chromosomes Cancer. 2011. PMID: 21213368
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.
Ou WB, Hubert C, Corson JM, Bueno R, Flynn DL, Sugarbaker DJ, Fletcher JA. Ou WB, et al. Neoplasia. 2011 Jan;13(1):12-22. doi: 10.1593/neo.101156. Neoplasia. 2011. PMID: 21245936 Free PMC article.
Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.
Jiao Y, Ou W, Meng F, Zhou H, Wang A. Jiao Y, et al. Among authors: ou w. Mol Cancer. 2011 Sep 30;10:125. doi: 10.1186/1476-4598-10-125. Mol Cancer. 2011. PMID: 21962244 Free PMC article.
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJ, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA. Lee CH, et al. Among authors: ou wb. Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):929-34. doi: 10.1073/pnas.1115528109. Epub 2012 Jan 5. Proc Natl Acad Sci U S A. 2012. PMID: 22223660 Free PMC article.
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Lee CH, Mariño-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M, Dal Cin P, Fletcher JA, Nucci MR. Lee CH, et al. Among authors: ou w. Am J Surg Pathol. 2012 May;36(5):641-53. doi: 10.1097/PAS.0b013e31824a7b1a. Am J Surg Pathol. 2012. PMID: 22456610
Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3.
Yang P, Chen W, Li X, Eilers G, He Q, Liu L, Wu Y, Wu Y, Yu W, Fletcher JA, Ou WB. Yang P, et al. Among authors: ou wb. Oncotarget. 2016 May 31;7(22):32652-63. doi: 10.18632/oncotarget.8999. Oncotarget. 2016. PMID: 27129163 Free PMC article.
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
Ou WB, Lu M, Eilers G, Li H, Ding J, Meng X, Wu Y, He Q, Sheng Q, Zhou HM, Fletcher JA. Ou WB, et al. Br J Cancer. 2016 Nov 8;115(10):1253-1263. doi: 10.1038/bjc.2016.331. Epub 2016 Oct 13. Br J Cancer. 2016. PMID: 27736841 Free PMC article.
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC, Li CF, Huang HY, Zhu MJ, Mariño-Enríquez A, Lee CT, Ou WB, Hornick JL, Fletcher JA. Lee JC, et al. Among authors: ou wb. J Pathol. 2017 Feb;241(3):316-323. doi: 10.1002/path.4836. Epub 2016 Dec 15. J Pathol. 2017. PMID: 27874193 Free PMC article. Review.
Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors.
Chen W, Kuang Y, Qiu HB, Cao Z, Tu Y, Sheng Q, Eilers G, He Q, Li HL, Zhu M, Wang Y, Zhang R, Wu Y, Meng F, Fletcher JA, Ou WB. Chen W, et al. Among authors: ou wb. Cancer Res. 2017 Sep 15;77(18):5107-5117. doi: 10.1158/0008-5472.CAN-17-0917. Epub 2017 Jul 31. Cancer Res. 2017. PMID: 28760855
Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.
Tu Y, Zuo R, Ni N, Eilers G, Wu D, Pei Y, Nie Z, Wu Y, Wu Y, Ou WB. Tu Y, et al. Among authors: ou wb. Cell Cycle. 2018;17(23):2577-2592. doi: 10.1080/15384101.2018.1553335. Epub 2018 Dec 4. Cell Cycle. 2018. PMID: 30488756 Free PMC article.
45 results
Jump to page